BN IMMUNOTHERAPEUTICS INC has a total of 17 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are PHARMEXA INC, MEMGEN LLC and MOLECULAR EXPRESS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | New Zealand | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Laus Reiner | 11 |
#2 | Mandl Stefanie | 11 |
#3 | Delcayre Alain | 11 |
#4 | Legrand Fatema | 7 |
#5 | Rountree Ryan Blair | 7 |
#6 | Nielsen Klaus Gregorius | 6 |
#7 | Eskling Marie | 4 |
#8 | Karlsson Gunilla | 2 |
#9 | Gautam Anand | 2 |
#10 | Steinaa Lucilla | 2 |